Predictive value of Ki-67 expression in predicting pathological response to neoadjuvant chemotherapy combined with immunotherapy in lung squamous cell carcinoma.

Importantly, our multivariate analysis already adjusted for all major clinicopathological confounders (age, gender, smoking status, clinical stage, PD-L1), and the association between Ki-67 and MPR/pCR remained highly significant (adjusted OR per 1% increase = 1.069, P < 0.001), suggesting that the observed predictive value is robust against measured confounding.

also in 132,142 other papers